Effects of elayed-release Dimethyl Fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM Studies - Kita, M; Fox, R J; Gold, R (Clin Ther, 2014)
et al.